The Business Times
business-time-50

Startups

Nvidia-backed startup Reflection unveils open-weight AI model said to rival China offerings

2026-10-06T05:09:30.000Z
Joe Lu, HeyMax CEO and co-founder, says HeyMax First is the outcome of the aspiration to fly comfortably, cheaper and faster.

HeyMax wants to challenge the miles game with ‘fly now, earn later’ model

2026-10-02T07:05:09.000Z
The honourees of this year’s NGT30 were announced on Sep 30. The programme is Asia’s first public-private initiative to recognise the region’s top growth-stage tech firms.

Asia’s top tech startups move beyond software towards physical AI

2026-09-30T05:34:39.000Z
The bulk of the growth in Syfe’s assets under management has been from existing users, says Dhruv Arora, CEO and founder of the wealth platform.

Syfe crosses S$20 billion AUM mark, tracks growth from investment and trading segments

2026-09-22T00:00:00.000Z
Anthropic’s backers include Amazon and Google, who are also its major compute suppliers. 

Nvidia in talks to invest in Anthropic’s mega IPO: sources

2026-09-12T03:55:26.000Z
The new models being rolled out will include new functions, such as being able to generate a song from audio, images and video inspirations.

AI music startup Suno launches new models that pay labels

2026-09-10T09:37:45.000Z
Arthur Mensch, co-founder and CEO of Mistral, says the funding round will allow the company to pick up the pace on R&D, products and infrastructure.

Mistral raises record 3 billion euros in Samsung-led round at over 21 billion euro valuation

2026-09-08T05:00:00.000Z
A recent survey found that 64% of Singapore’s financial institutions are actively deploying AI across key business functions.

AI startup aiming to be banks’ ‘top-to-bottom operating system’ sets up Singapore hub

2026-08-26T03:59:41.000Z
There is intensifying competition in the biotech space, but Huang believes that K2 Therapeutics’ hub-and-spoke model should give it the edge.

Singapore-based biotech K2 Therapeutics secures US$50 million seed round; appoints Huang Ying as CEO

2026-08-11T12:00:00.000Z
The biotech industry is in its own microcosm, unaffected by geopolitics, says Peter Kash, executive chairman of Camelot BioCapital.

Biotech transcends geopolitics as family offices fuel next wave of innovation: Camelot BioCapital’s Peter Kash

2026-08-10T23:00:00.000Z
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More